Cargando…

MON-490 Calcitonin-Based Thyroidectomy Is a Safe Approach in Patients with Germline RET Mutation and Permits to Delay Surgery in Children

Introduction: Medullary thyroid cancer (MTC) arises from C cells secreting calcitonin. In familial MTC cases, a germline RET mutation is discovered in 98% of cases. Nowadays, an early diagnosis and radical surgery are the only curative approach. However, thyroidectomy in children is associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Prete, Alessandro, Romei, Cristina, Tacito, Alessia, Ramone, Teresa, Bottici, Valeria, cappagli, virginia, Viola, David, Matrone, Antonio, Agate, Laura, Lorusso, Loredana, Valerio, Laura, Giani, Carlotta, Puleo, Luciana, Molinaro, Eleonora, Elisei, Rossella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207461/
http://dx.doi.org/10.1210/jendso/bvaa046.1331
_version_ 1783530610857345024
author Prete, Alessandro
Romei, Cristina
Tacito, Alessia
Ramone, Teresa
Bottici, Valeria
cappagli, virginia
Viola, David
Matrone, Antonio
Agate, Laura
Lorusso, Loredana
Valerio, Laura
Giani, Carlotta
Puleo, Luciana
Molinaro, Eleonora
Elisei, Rossella
author_facet Prete, Alessandro
Romei, Cristina
Tacito, Alessia
Ramone, Teresa
Bottici, Valeria
cappagli, virginia
Viola, David
Matrone, Antonio
Agate, Laura
Lorusso, Loredana
Valerio, Laura
Giani, Carlotta
Puleo, Luciana
Molinaro, Eleonora
Elisei, Rossella
author_sort Prete, Alessandro
collection PubMed
description Introduction: Medullary thyroid cancer (MTC) arises from C cells secreting calcitonin. In familial MTC cases, a germline RET mutation is discovered in 98% of cases. Nowadays, an early diagnosis and radical surgery are the only curative approach. However, thyroidectomy in children is associated with a higher rate of surgical adverse events, compared to surgery in adults. The best clinical approach in patient harboring germline RET mutation (gene carriers, GC) is still undefined. Methods and materials: since 1994 to 2018 we identified 174 GC by RET screening. 56 GC underwent total thyroidectomy and lymph node dissection for the evidence of high calcitonin levels at the first clinical evaluation, whereas 27 GC underwent surgery for high stimulated calcitonin levels during the active surveillance (median 16 months, range 13-118). 90 GC are still in follow up. Results: In the group of 27 GC patients who underwent surgery during the active surveillance, 15 GC had only C cells hyperplasia (CCH) foci and 12 were affected by MTC. These carcinomas were all confined to the thyroid, without any lymph node and distant metastasis. All these patients are still in clinical remission, after a median follow-up of 4 years (range 1-11). At time of the surgery, the patients affected by MTC were significantly older than patients harboring only CCH (median 49 vs 30 years old, respectively). Among these 27 GC, 7 were diagnosed as GC when they were younger than 18 years (median 7 years old, range 2-18) and they underwent surgery after a median period of 3 years (range 1-10 years), when they were all older than 7 years. In this group, 6 of 7 were affected by CCH and only one case by a microMTC. There were not any persistent surgical adverse events and all of them are still in clinical remission. 41 of 90 GC, who are still in active surveillance, were younger than 18 years at time of RET screening: nowadays, 10/41 are older than 18 years and 15/41 are older than 14 years, all with calcitonin still in the normal range. Conclusions: we demonstrated that the calcitonin-based thyroidectomy is a safe approach in GC. Intriguingly, this approach seems to be interesting especially in children in order to perform still an early and safe surgery but when they are older, possibly adults.
format Online
Article
Text
id pubmed-7207461
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72074612020-05-13 MON-490 Calcitonin-Based Thyroidectomy Is a Safe Approach in Patients with Germline RET Mutation and Permits to Delay Surgery in Children Prete, Alessandro Romei, Cristina Tacito, Alessia Ramone, Teresa Bottici, Valeria cappagli, virginia Viola, David Matrone, Antonio Agate, Laura Lorusso, Loredana Valerio, Laura Giani, Carlotta Puleo, Luciana Molinaro, Eleonora Elisei, Rossella J Endocr Soc Thyroid Introduction: Medullary thyroid cancer (MTC) arises from C cells secreting calcitonin. In familial MTC cases, a germline RET mutation is discovered in 98% of cases. Nowadays, an early diagnosis and radical surgery are the only curative approach. However, thyroidectomy in children is associated with a higher rate of surgical adverse events, compared to surgery in adults. The best clinical approach in patient harboring germline RET mutation (gene carriers, GC) is still undefined. Methods and materials: since 1994 to 2018 we identified 174 GC by RET screening. 56 GC underwent total thyroidectomy and lymph node dissection for the evidence of high calcitonin levels at the first clinical evaluation, whereas 27 GC underwent surgery for high stimulated calcitonin levels during the active surveillance (median 16 months, range 13-118). 90 GC are still in follow up. Results: In the group of 27 GC patients who underwent surgery during the active surveillance, 15 GC had only C cells hyperplasia (CCH) foci and 12 were affected by MTC. These carcinomas were all confined to the thyroid, without any lymph node and distant metastasis. All these patients are still in clinical remission, after a median follow-up of 4 years (range 1-11). At time of the surgery, the patients affected by MTC were significantly older than patients harboring only CCH (median 49 vs 30 years old, respectively). Among these 27 GC, 7 were diagnosed as GC when they were younger than 18 years (median 7 years old, range 2-18) and they underwent surgery after a median period of 3 years (range 1-10 years), when they were all older than 7 years. In this group, 6 of 7 were affected by CCH and only one case by a microMTC. There were not any persistent surgical adverse events and all of them are still in clinical remission. 41 of 90 GC, who are still in active surveillance, were younger than 18 years at time of RET screening: nowadays, 10/41 are older than 18 years and 15/41 are older than 14 years, all with calcitonin still in the normal range. Conclusions: we demonstrated that the calcitonin-based thyroidectomy is a safe approach in GC. Intriguingly, this approach seems to be interesting especially in children in order to perform still an early and safe surgery but when they are older, possibly adults. Oxford University Press 2020-05-08 /pmc/articles/PMC7207461/ http://dx.doi.org/10.1210/jendso/bvaa046.1331 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Thyroid
Prete, Alessandro
Romei, Cristina
Tacito, Alessia
Ramone, Teresa
Bottici, Valeria
cappagli, virginia
Viola, David
Matrone, Antonio
Agate, Laura
Lorusso, Loredana
Valerio, Laura
Giani, Carlotta
Puleo, Luciana
Molinaro, Eleonora
Elisei, Rossella
MON-490 Calcitonin-Based Thyroidectomy Is a Safe Approach in Patients with Germline RET Mutation and Permits to Delay Surgery in Children
title MON-490 Calcitonin-Based Thyroidectomy Is a Safe Approach in Patients with Germline RET Mutation and Permits to Delay Surgery in Children
title_full MON-490 Calcitonin-Based Thyroidectomy Is a Safe Approach in Patients with Germline RET Mutation and Permits to Delay Surgery in Children
title_fullStr MON-490 Calcitonin-Based Thyroidectomy Is a Safe Approach in Patients with Germline RET Mutation and Permits to Delay Surgery in Children
title_full_unstemmed MON-490 Calcitonin-Based Thyroidectomy Is a Safe Approach in Patients with Germline RET Mutation and Permits to Delay Surgery in Children
title_short MON-490 Calcitonin-Based Thyroidectomy Is a Safe Approach in Patients with Germline RET Mutation and Permits to Delay Surgery in Children
title_sort mon-490 calcitonin-based thyroidectomy is a safe approach in patients with germline ret mutation and permits to delay surgery in children
topic Thyroid
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207461/
http://dx.doi.org/10.1210/jendso/bvaa046.1331
work_keys_str_mv AT pretealessandro mon490calcitoninbasedthyroidectomyisasafeapproachinpatientswithgermlineretmutationandpermitstodelaysurgeryinchildren
AT romeicristina mon490calcitoninbasedthyroidectomyisasafeapproachinpatientswithgermlineretmutationandpermitstodelaysurgeryinchildren
AT tacitoalessia mon490calcitoninbasedthyroidectomyisasafeapproachinpatientswithgermlineretmutationandpermitstodelaysurgeryinchildren
AT ramoneteresa mon490calcitoninbasedthyroidectomyisasafeapproachinpatientswithgermlineretmutationandpermitstodelaysurgeryinchildren
AT botticivaleria mon490calcitoninbasedthyroidectomyisasafeapproachinpatientswithgermlineretmutationandpermitstodelaysurgeryinchildren
AT cappaglivirginia mon490calcitoninbasedthyroidectomyisasafeapproachinpatientswithgermlineretmutationandpermitstodelaysurgeryinchildren
AT violadavid mon490calcitoninbasedthyroidectomyisasafeapproachinpatientswithgermlineretmutationandpermitstodelaysurgeryinchildren
AT matroneantonio mon490calcitoninbasedthyroidectomyisasafeapproachinpatientswithgermlineretmutationandpermitstodelaysurgeryinchildren
AT agatelaura mon490calcitoninbasedthyroidectomyisasafeapproachinpatientswithgermlineretmutationandpermitstodelaysurgeryinchildren
AT lorussoloredana mon490calcitoninbasedthyroidectomyisasafeapproachinpatientswithgermlineretmutationandpermitstodelaysurgeryinchildren
AT valeriolaura mon490calcitoninbasedthyroidectomyisasafeapproachinpatientswithgermlineretmutationandpermitstodelaysurgeryinchildren
AT gianicarlotta mon490calcitoninbasedthyroidectomyisasafeapproachinpatientswithgermlineretmutationandpermitstodelaysurgeryinchildren
AT puleoluciana mon490calcitoninbasedthyroidectomyisasafeapproachinpatientswithgermlineretmutationandpermitstodelaysurgeryinchildren
AT molinaroeleonora mon490calcitoninbasedthyroidectomyisasafeapproachinpatientswithgermlineretmutationandpermitstodelaysurgeryinchildren
AT eliseirossella mon490calcitoninbasedthyroidectomyisasafeapproachinpatientswithgermlineretmutationandpermitstodelaysurgeryinchildren